AI assistant
Sending…
STAAR SURGICAL CO — Director's Dealing 2016
Dec 9, 2016
31996_dirs_2016-12-09_4463e98d-2caa-4c11-af6b-02fceea0315b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: STAAR SURGICAL CO (STAA)
CIK: 0000718937
Period of Report: 2016-12-08
Reporting Person: Blickensdoerfer Hans-Martin (Sr. VP, EMEA, LA and China)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-12-08 | Common Stock | M | 20680 | $5.39 | Acquired | 137380 | Direct |
| 2016-12-08 | Common Stock | S | 20680 | $11.1021 | Disposed | 116700 | Direct |
| 2016-12-09 | Common Stock | M | 4320 | $5.39 | Acquired | 121029 | Direct |
| 2016-12-09 | Common Stock | S | 4320 | $11.3164 | Disposed | 116700 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2016-12-08 | Common Stock Option | $5.39 | M | 20680 | Disposed | 2016-04-01 | Common Stock (25000) | Direct |
| 2016-12-09 | Common Stock Option | $5.39 | M | 4320 | Disposed | 2016-04-01 | Common Stock (4320) | Direct |
Footnotes
F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.10 to $11.15, inclusive.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.20 to $11.35, inclusive.
F3: The option vested in three equal installments on April 2, 2008, April 2, 2009, and April 2, 2010.
More from STAAR SURGICAL CO
Interim / Quarterly Report
2026
May 13
Regulatory Filings
2026
May 13
Major Shareholding Notification
2026
May 12
Annual Report
2026
May 4
Proxy Solicitation & Information Statement
2026
May 4
Proxy Solicitation & Information Statement
2026
May 4
Major Shareholding Notification
2026
Apr 24
Major Shareholding Notification
2026
Apr 20
Regulatory Filings
2026
Apr 8
Major Shareholding Notification
2026
Mar 27